Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
40 studies found for:    " April 09, 2008":" May 09, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed The Influence of Raltegravir on Pravastatin Pharmacokinetics(GRAPPA)
Condition: HIV Infections
Interventions: Drug: Pravastatin;   Drug: Raltegravir;   Drug: Pravastatin and raltegravir
22 Terminated Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in co-Infected HIV/HCV Patients
Condition: HIV Infections
Interventions: Drug: Lopinavir/ritonavir;   Drug: Nevirapine
23 Completed
Has Results
Pilot Project of Virologic and Immunologic Correlates of GALT Immune Reconstitution Following Raltegravir Therapy
Conditions: HIV Infections;   AIDS
Interventions: Drug: raltegravir;   Drug: efavirenz
24 Completed Sex, Aging and Antiretroviral Pharmacokinetics
Condition: HIV Infections
Intervention: Drug: ARV regimen chosen by treating physician
25 Suspended Study Of The Efficacy And Security Of Ibandronate For Osteoporosis Treatment In A HIV-Infected Patients Cohort
Condition: HIV Infections
Interventions: Drug: Ibandronate;   Behavioral: Lifestyle modifications
26 Unknown  Pilot Study to Determine the Safety and Efficacy of Gardasil Against the Human Papilloma Virus (HPV) in HIV-infected Men
Conditions: Anal Cancer;   HIV Infections
Intervention: Biological: Gardasil
27 Unknown  Follow-up on the HIGH: Low Study - the Longterm Effects of Growth Hormone
Conditions: HIV Infections;   HIV-Associated Lipodystrophy Syndrome
Intervention:
28 Terminated
Has Results
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Conditions: HIV Infections;   Hyperlipidemia
Intervention: Drug: Atorvastatin
29 Terminated Effectiveness of Rosuvastatin at Preventing the Progression of Atherosclerosis in HIV Positive Patients
Conditions: Atherosclerosis;   HIV Infections
Interventions: Drug: Rosuvastatin;   Drug: Placebo
30 Completed Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST)
Conditions: Hepatitis B;   HIV Infection
Intervention: Biological: GenHevac-B
31 Completed
Has Results
Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection
Conditions: HIV Infections;   Hepatitis B
Interventions: Drug: Entecavir with continued standard of care antiretroviral therapy;   Drug: continued standard of care with tenofovir in addition to emtricitabine or lamivudine
32 Unknown  Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV)
Conditions: HIV-hepatitis Co-infection;   HIV Infections
Intervention:
33 Active, not recruiting Prospective Observational Epidemiologic Study of Maraviroc's Safety
Condition: Human Immunodeficiency Virus
Interventions: Drug: Maraviroc along with an optimized background antiretroviral drug regimen;   Drug: Optimized background antiretroviral drug regimen without maraviroc
34 Completed
Has Results
Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance
Condition: HIV-1 and Hepatitis C Co-Infection
Interventions: Drug: pioglitazone;   Drug: peginterferon;   Drug: ribavirin
35 Unknown  A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected Patients
Conditions: HIV Infections;   Hepatitis B Virus
Intervention:
36 Completed Effectiveness of Community-Level Behavioral and Biomedical Interventions for Reducing HIV/STIs in Men in Peru
Conditions: HIV Infections;   Sexually Transmitted Infections
Interventions: Behavioral: Enhanced Partner Therapy (EPT);   Behavioral: Communidades Positivas (CPOS);   Behavioral: Standard Care
37 Completed
Has Results
TMC125-TiDP35-C213: Safety and Antiviral Activity of Etravirine (TMC125) in Treatment-Experienced, HIV Infected Children and Adolescents
Condition: HIV-1
Interventions: Drug: Etravirine (TMC125);   Drug: Optimized background regimen (OBR)
38 Completed
Has Results
Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV
Condition: HIV I Infection
Interventions: Drug: Vacc-4x;   Drug: Sterile water
39 Completed
Has Results
Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome
Conditions: HIV Infections;   Cardiovascular Disease;   Insulin Resistance;   HIV Lipodystrophy;   The Metabolic Syndrome
Interventions: Drug: Pioglitazone;   Behavioral: Exercise Training
40 Completed
Has Results
Vaccine Therapy in Preventing HPV in HIV-Positive Women in India
Conditions: Cervical Cancer;   Nonneoplastic Condition;   Precancerous Condition
Interventions: Biological: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine;   Genetic: DNA analysis;   Genetic: polymerase chain reaction;   Other: cytology specimen collection procedure;   Procedure: colposcopic biopsy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page   
Study has passed its completion date and status has not been verified in more than two years.